Decision of the EEA Joint Committee No 232/2025 of 24 October 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/221]

**Executive Summary** This document is a Decision of the EEA Joint Committee No 232/2025, dated October 24, 2025, amending Annex II of the EEA Agreement. It incorporates Commission Regulation (EU) 2025/1150 regarding the use of sodium ascorbate in infant formula into the EEA Agreement. The decision enters into force on October 25, 2025, provided all notifications under Article 103(1) of the EEA Agreement have been made. **Key Points / Main Content** * **Amendment to Annex II:** * A new indent is added to Chapter XII of Annex II to the EEA Agreement, referencing Regulation (EC) No 1333/2008. * The indent specifically includes Commission Regulation (EU) 2025/1150 of 11 June 2025, concerning the use of sodium ascorbate in vitamin A preparations for infant formula and follow-on formula. * **Authentic Text:** * The text of Regulation (EU) 2025/1150 is to be published in the Icelandic and Norwegian languages in the EEA Supplement to the Official Journal of the European Union and will be considered authentic. * **Entry into Force:** * The Decision enters into force on October 25, 2025, after all notifications under Article 103(1) of the EEA Agreement have been completed. * **Publication:** * This Decision will be published in the EEA Section of the Official Journal of the European Union and its EEA Supplement. * **Liechtenstein Exclusion:** * This Decision does not apply to Liechtenstein due to its agreement with the Swiss Confederation on trade in agricultural products. **Impact Analysis** **European Economic Area (EEA) Participants:** * **Impact:** EEA member states are bound to incorporate Commission Regulation (EU) 2025/1150 into their national regulations. * **Action Required:** Implement the regulation regarding the use of sodium ascorbate in vitamin A preparations for infant formula and follow-on formula. **Food Producers (Manufacturing Infant Formula):** * **Impact:** Must adhere to the new regulations regarding the use of sodium ascorbate in vitamin A preparations for infant and follow-on formula in products sold within the EEA. * **Action Required:** Review and adjust their manufacturing processes and product formulations to comply with Regulation (EU) 2025/1150. **EEA Joint Committee:** * **Impact:** Ensures the proper implementation and publication of the Decision. * **Action Required:** Monitor the notification process under Article 103(1) of the EEA Agreement and oversee the publication of the Decision.

Key Entities Referenced